TWENTE Study: The Real-World Endeavor Resolute Versus Xience V Drug-Eluting Stent Study in Twente: study design, rationale and objectives

被引：12

作者：

Basalus, M. W. Z. ^{[1
]}

Tandjung, K. ^{[1
]}

van Houwelingen, K. G. ^{[1
]}

Stoel, M. G. ^{[1
]}

de Man, F. H. A. F. ^{[1
]}

Louwerenburg, J. W. ^{[1
]}

Said, S. A. M. ^{[3
]}

Linssen, G. C. M. ^{[4
]}

Kleijne, M. A. W. J. ^{[5
]}

van der Palen, J. ^{[6
,7
]}

Huisman, J. ^{[1
]}

Verhorst, P. M. J. ^{[1
]}

von Birgelen, C. ^{[1
,2
]}

机构：

[1] Medisch Spectrum Twente, Dept Cardiol, Thoraxctr Twente, NL-7500 KA Enschede, Netherlands

[2] Univ Twente, MIRA, Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands

[3] Hosp Grp Twente, Dept Cardiol, Hengelo, Netherlands

[4] Hosp Grp Twente, Dept Cardiol, Almelo, Netherlands

[5] Streekziekenhuis Koningin Beatrix, Dept Cardiol, Winterswijk, Netherlands

[6] Medisch Spectrum Twente, Dept Epidemiol, NL-7500 KA Enschede, Netherlands

[7] Univ Twente, Dept Res Methodol Measurement & Data Anal, NL-7500 AE Enschede, Netherlands

来源：

NETHERLANDS HEART JOURNAL | 2010年 / 18卷 / 7-8期

关键词：

Drug-Eluting Stents; Coronary Artery Diseases; Angioplasty; Transluminal; Percutaneous Coronary; Thrombosis; Randomized Controlled Trial; CORONARY-ARTERY-DISEASE; BARE-METAL STENTS; CLINICAL FOLLOW-UP; RANDOMIZED-TRIAL; INTRAVASCULAR ULTRASOUND; IMPLANTATION; METAANALYSIS; THROMBOSIS; EFFICACY; SYSTEM;

D O I：

10.1007/BF03091792

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background. New-generation drug-eluting stents (DES) may solve several problems encountered with first-generation DES, but there is a lack of prospective head-to-head comparisons between new-generation DES. In addition, the outcome of regulatory trials may not perfectly reflect the outcome in 'real world' patients. Objectives. To compare the efficacy and safety of two new-generation DES in a 'real world' patient population. Methods. A prospective, randomised, single-blinded clinical trial to evaluate clinical outcome after Endeavor Resolute vs. Xience V stent implantation. The primary endpoint is target vessel failure at one-year follow-up. In addition, the study comprises a two-year and an open-label five-year follow-up. (Neth Heart J 2010;18:360-4.)

引用

页码：360 / 364

页数：5

共 29 条

[1] Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy [J].

Basalus, Mounir W. Z. ;

Ankone, Marc J. K. ;

van Houwelingen, K. Gert ;

de Man, Frits H. A. F. ;

von Birgelen, Clemens .

EUROINTERVENTION, 2009, 5 (01) :157-165

[2]

BASALUS MW, 2010, J INTERV CARDIOL, V2, P159

[3] Sirolimus-eluting stent implantation in diabetic patients with multivessel coronary artery disease [J].

Briguori, C ;

Colombo, A ;

Airoldi, F ;

Focaccio, A ;

Iakovou, L ;

Chieffo, A ;

Michev, I ;

Montorfano, M ;

Bonizzoni, E ;

Ricciardelli, B ;

Condorelli, G .

AMERICAN HEART JOURNAL, 2005, 150 (04) :807-813

[4] Experimental efficacy of an everolimus eluting cobalt chromium stent [J].

Carter, AJ ;

Brodeur, A ;

Collingwood, R ;

Ross, S ;

Gibson, L ;

Wang, CA ;

Haller, S ;

Coleman, L ;

Virmani, R .

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2006, 68 (01) :97-103

[5] Clinical end points in coronary stent trials - A case for standardized definitions [J].

Cutlip, Donald E. ;

Windecker, Stephan ;

Mehran, Roxana ;

Boam, Ashley ;

Cohen, David J. ;

van Es, Gerrit-Anne ;

Steg, P. Gabriel ;

Morel, Marie-angele ;

Mauri, Laura ;

Vranckx, Pascal ;

McFadden, Eugene ;

Lansky, Alexandra ;

Hamon, Martial ;

Krucoff, Mitchell W. ;

Serruys, Patrick W. .

CIRCULATION, 2007, 115 (17) :2344-2351

[6] Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice:: data from a large two-institutional cohort study [J].

Daemen, Joost ;

Wenaweser, Peter ;

Tsuchida, Keiichi ;

Abrecht, Linda ;

Sophia, Vaina ;

Morger, Cyrill ;

Kukreja, Neville ;

Jueni, Peter ;

Sianos, Georgios ;

Hellige, Gerrit ;

van Domburg, Ron T. ;

Hess, Otto M. ;

Boersma, Eric ;

Meier, Bernhard ;

Windecker, Stephan ;

Serruys, Patrick W. .

LANCET, 2007, 369 (9562) :667-678

[7] Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents -: Three-year results of the RAVEL trial [J].

Fajadet, J ;

Morice, MC ;

Bode, C ;

Barragan, P ;

Serruys, PW ;

Wijns, W ;

Constantini, CR ;

Guermonprez, JL ;

Eltchaninoff, H ;

Blanchard, D ;

Bartorelli, A ;

Laarman, GJ ;

Perin, MA ;

Sousa, JE ;

Schuler, G ;

Molnar, F ;

Guagliumi, G ;

Colombo, A ;

Hayashi, EB ;

Wülfert, E .

CIRCULATION, 2005, 111 (08) :1040-1044

[8] Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice -: The SORT OUT II Randomized trial [J].

Galloe, Anders M. ;

Thuesen, Leif ;

Kelbaek, Henning ;

Thayssen, Per ;

Rasmussen, Klaus ;

Hansen, Peter R. ;

Bligaard, Niels ;

Saunamaki, Kari ;

Junker, Anders ;

Aaroe, Jens ;

Abildgaard, Ulrik ;

Ravkilde, Jan ;

Engstrom, Thomas ;

Jensen, Jan S. ;

Andersen, Henning R. ;

Botker, Hans E. ;

Galatius, Soren ;

Kristensen, Steen D. ;

Madsen, Jan K. ;

Krusell, Lars R. ;

Abildstrom, Steen Z. ;

Stephansen, Ghita B. ;

Lassen, Jens F. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (04) :409-416

[9] Novel High Throughput Polymer Biocompatibility Screening Designed for SAR (Structure-Activity Relationship): Application for Evaluating Polymer Coatings for Cardiovascular Drug-Eluting Stents [J].

Hezi-Yamit, Ayala ;

Sullivan, Carol ;

Wong, Jennifer ;

David, Laura ;

Chen, Mingfei ;

Cheng, Peiwen ;

Shumaker, David ;

Wilcox, Josiah ;

Udipi, Kishore .

COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2009, 12 (07) :664-676

[10] Endothelial cell recovery between comparator polymer-based drug-eluting stents [J].

Joner, Michael ;

Nakazawa, Gaku ;

Finn, Aloke V. ;

Quee, Shawn Chin ;

Coleman, Leslie ;

Acampado, Eduardo ;

Wilson, Patricia S. ;

Skorija, Kristi ;

Cheng, Qi ;

Xu, Xin ;

Gold, Herman K. ;

Kolodgie, Frank D. ;

Virmani, Renu .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (05) :333-342

← 1 2 3 →